Chronic Hepatitis B Virus Infection research hub
3 indexed studies · 2 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects with Chronic Hepatitis B Virus Infection
This clinical study tests new treatments for chronic hepatitis B, a long-term liver infection. Researchers want to see if combining experimental medicines with an existing drug called interferon can safely lower the amount of virus in the body, working towards a long-lasting cure without needing daily tablets for life.
Romania · Germany - recruitingHuman Pharmacology (Phase I)- First administration to humans
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subjects
This early-stage study is testing a new medicine called AB-101 for people with long-term hepatitis B. Researchers want to see if it's safe, how the body handles it, and if it starts to work. It's the first time this medicine is being given to people.
Romania · Italy · Bulgaria - active not recruitingPHASE2
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
This study is testing new medicines, daplusiran/tomligisiran (DAP/TOM) and bepirovirsen, for people with long-term Hepatitis B. It aims to find the best dose of DAP/TOM to use with bepirovirsen to improve treatment.
United States · Australia · Belgium